Key result
Early circulating levels of plasma MMP-2 measured before and after primary PCI were significantly correlated with infarct size and left ventricular dysfunction at 5 days and 4 months in STEMI patients.
Why the study?
Do early measurements of plasma MMP-2 predict infarct size and ventricular dysfunction in patients with STEMI undergoing primary PCI?
Population
58 patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
Design
Cohort
Follow-up
4 months
Authors
Loading...
Early MMP-2 levels may aid post-STEMI risk stratification; leaves open clinical utility pending prospective validation.
Cohort (n=58)
Do early measurements of plasma MMP-2 predict infarct size and ventricular dysfunction in patients with STEMI undergoing primary PCI?
Early measurement of plasma MMP-2 before and shortly after primary PCI in STEMI patients predicts subsequent infarct size and left ventricular dysfunction.
Nilsson et al. (2011) conducted a cohort in ST-elevation myocardial infarction (STEMI) (n=58). Plasma MMP-2 levels was evaluated on Infarct size and left ventricular dysfunction assessed by cardiac MRI. Early circulating levels of plasma MMP-2 measured before and after primary PCI were significantly correlated with infarct size and left ventricular dysfunction at 5 days and 4 months in STEMI patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: